The SARS-CoV-2 pandemic has rained challenges on laboratories from all sides, including supply chain problems, reporting issues, reimbursement concerns, decline in routine testing, and more. Flexible strategies have had to be adopted to keep up with the demand for testing and help address the spread of COVID-19.
Point-of-Care Testing (POCT) was already increasing in demand, but is now more in the spotlight due to the novel coronavirus pandemic and the need to quickly act to lessen the virus’ deadly impact. While the lesser sensitivity and specificity of POCT is acknowledged as an issue, its rapid TAT is a worthwhile trade-off in patient scenarios where speed is of the essence. Rapid POCT is being introduced as part of an overall plan to help address the COVID-19 testing backlog and delayed turnaround times.
The nuances of POCT require oversight by laboratorians who understand exactly what is required to achieve accurate results. Laboratory professionals are instrumental in ensuring the proper implementation and performance of POCT. Read more in our white paper: How the Novel Coronavirus Pandemic of 2020 Spotlights the Value of POCT.